Embodiments of this disclosure are directed to electrodes and lead designs for use in medical procedures.
Examples of leads and their uses are described in U.S. Pat. No. 9,682,235; U.S. Pat. No. 8,903,508 and U.S. Pat. No. 8,167,640; the entire contents of each being incorporated herein by reference.
This disclosure herein relates to the placement of electrically stimulateable leads using a through the needle (TTN) approach and visibility under ultrasound. Electrically stimulateable needles visible under ultrasound are current commercially available. The lead may have one or more electrodes discloses designs that make it ultrasonically visible. The TTN approach is often limited by the size of the lead or catheter that is being deployed through the needle inner lumen and other methods such as peel away introducers and the seldinger technique may in some cases be used instead when applicable. These methods are not as useful for subcutaneous procedures where the device being deployed does not have the luxury of being pushed past the tip of the deployment device due to the presence of tissue. The ability to visualize the lead with respect to its anatomical location using ultrasound imaging is also important after removal of the needle. The needle is typically withdrawn leaving the lead in place. Knowing the location of the lead is critical after its deployment.
Solid electrodes such as cylindrical electrodes used in the areas of deep brain stimulation, spinal cord stimulation, phrenic nerve stimulation, peripheral nerve stimulation etc., suffer from the limitation that the diameter has to increase to increase surface area of the cylindrical electrode because the use of non-coring needles requires a bend in the inner lumen at the tip thereby limiting the length of the electrode which can pass through the turn radius. There are a number of non-coring needle designs such as Tuohy, Sprotte, Whitacre etc. commercially available. Each of these needles have a turn radius in the lumen path near the needle tip to prevent tissue coring and generally keep the lumen path at right angles to the plane of insertion at the needle tip. This bend in the lumen limits the length of the electrode that can pass through the needle and requires the use of larger needle diameters when larger surface area electrodes are required especially with commonly used inline cylindrical electrodes. The radius of the internal lumen bend is the limiting factor in the length of the electrode that may safely pass and typically also increases with the gauge of the needle. Unfortunately, larger needles result in an increase in trauma to the patient during the lead insertion process. There is a limitation in the maximum needle diameter that can be safely inserted subcutaneously in patients which is also a function of the surrounding anatomy and tissue. The larger the needle diameter the higher the insertion force and the less sensitivity the clinician has to feeling the surrounding tissue. This tactile feedback and the skill of the clinician are often critical to the safety of a procedure.
There is a need for a lead electrode design that overcomes these limitations and facilitates large surface area electrodes fitting through curvilinear needle paths like Tuohy, Sprotte and other such non-coring needles visible under ultrasound imaging.
The present disclosure describes systems, methods and apparatus which may be used to deploy large surface area flexible circular electrodes using small non-coring needles which are visible under ultrasound imaging after deployment. The surface area of the electrode may be independent of the diameter size of the needle being used. The new limitation being the diameter of the electrode and the ability to perform assembly of the lead. At some point the resistance of the connection wires to the electrode will be the determining factor. Using smaller diameter electrodes has the advantage of minimizes tissue trauma during lead deployment and thus increases patient safety. Puncturing a vein or artery with a small needle has significantly less impact when compared to puncturing with a large diameter needle. In one of the embodiments a helical coiled electrode design cut from a tubular electrode is used to provide flexibility with solid cylindrical rings at both ends ensuring the coil cannot unravel during flexing and remain intact during use. The helical coil electrode may be laser cut from a single tube cylinder of suitable electrode material. A further embodiment of the electrode design being it may be made from two or three separate components and welded together during lead assembly. Alternative flexible electrode cut patterns to helical coils are also envisaged.
PRIOR ART
PRIOR ART
PRIOR ART
PRIOR ART
In medical implantation procedures of the type described herein, it is axiomatic that the smaller the diameter of the needle the less impact it will have on surrounding tissue when it is moved through tissue. This is main reason smaller needs are preferred in IV therapy and subcutaneous injections. This miniaturization of the diameter conflicts with requirement of having a large surface area electrode to minimize the charge density on the electrode surface area. Charge densities greater than 30 μCoulombs/cm2-phase have been shown by McCreery and Shannon to cause tissue damage. The Shannon criteria constitute an empirical rule in neural engineering that is used for evaluation of possibility of damage from electrical stimulation to nervous tissue. The Shannon criteria relate two parameters for pulsed electrical stimulation: charge density per phase, D (μC/(phase·cm2)) and charge per phase, Q (μC/phase).
The surface area of a cylindrical electrode is primarily a function of both the electrode diameter and its length. Surface roughness also plays a factor and may be increased at a microscopic level to get a many fold increase in electrode surface area. Unfortunately, the benefits of utilizing this approach is quickly lost in vitro has been reported in the literature, due to biomaterial adhering the microstructures on the surface.
The example lead in this disclosure was chosen to have a diameter of 0.87 mm such that it could fit through a commercially available echogenic electrical stimulateable Tuohy tipped needle with a 1 mm internal diameter lumen. The lead diameter could be designed and modified to fit through any needle or number of inner needle diameters or lumens and this specific example is being given for illustrative purposes only. The design of the electrode on the lead was also chosen to be echogenic under ultrasound making it visible once deployed through the needle. The sharp edges of the spiral cut of the helix enhances visible under ultrasound.
PRIOR ART
PRIOR ART
The larger the electrical current required to achieve electrical stimulation the greater the surface area of the electrode required to prevent tissue damage due to electrical stimulation. Damage caused by electrical stimulation is caused by a number of factors such as electrode materials, current shape of electrical stimulus, charge balance, irreversible Faradaic reactions etc. outlined by Merrill. In order to achieve a charge density requirement of 25 μC/cm2-phase, the electrode requires a length of 4 mm if it has a diameter of 0.87 mm when calculated using the Shannon criteria. This is too long in length to pass through curved lumen 108 of the 18G Tuohy tipped needle described in PRIOR ART
Implanted leads are known to fail due to fatigue and the use of known tried and tested standard techniques for wire attachment to electrodes and connectors to prevent fatigue failures is key to the success of lead reliability. Two of the most common failures and causes of recall in leads are wires breaking due to fatigue or the connection to the lead becoming disconnected.
In the embodiment shown, lead 400 may be one of several leads in communication with a stimulator which transmits an electric current to the electrodes 402 in order to stimulate a nerve or other anatomical structure. One example of a system with which the lead(s) 400 may be utilized or incorporated into is the PEPNS system described in U.S. Pat. No. 9,682,235, the entire contents of which are incorporated herein by reference.
An IS4 type connector or other such similar connector design may be used to provide connection to the contacts between the lead and the stimulator. The contacts provide electrical contacts to connect to an electrical stimulator. In this case contact 0, 401 is connected to electrode 0, 402 and contact 1 is connected to electrode 1 and so on. There are 4 electrodes 402 in this lead but many additional electrodes are possible using the configuration shown. The lead is supplied with marker bands 403 spaced at 100 and 200 mm intervals in the 300 mm length lead. The marker bands are used to help the user identify the length of the lead inserted into the patient. The lead body material between the leads, marker bands and contacts is made from a transparent polyurethane polymer providing flexibility and encapsulating the internal wires and electrical connections. A cross-section of one of the leads is shown in section A-A 408 along with the side view 412.
Coiled wires 405 have been historically used where flexibility and fatigue resistance are required. This coiled design also prevents the connections from coming under strain when the lead is under tensile forces. The number of individual wires coiled is a function of the number of electrodes used. In this case 4 coiled wires 405 are wound in parallel and each wire is connected to a contact 401 and electrode 402. The wires may be made from silver filled MP35N to minimize electrical resistance and provide maximum strength and fatigue resistance. The wire 405 is coated with an insulating material such as ETFE which is a copolymer of tetrafluoroethylene (TFE) and ethylene to prevent electrical shorting between wires. In section A-A 408 the connection of electrode 3 and the wire is shown as a swage crimp connection between the electrode ring 406 and the swage ring 411. The wire 407 which contains four wires, one for each electrode contains only 3 wires after it exists the electrode 415. Laser or electrical welding of the wire 407 to the ring electrode 406 are also possible. The ring connector 406 also provide an ideal area for this connection. The ring connectors, 406 and 409 were designed to be 0.8 mm in length and the helical laser cut electrode width to be 0.2 mm 414 with gaps of 05 mm between each helical ensuring the electrode can flex as it passed through the needle tip. These ratios may be varied depending upon the electrode flexibility required, the lead tensile strength requirements and the radius of the needle bend.
Electrode flexibility is achieved by cutting a helical shape in to the electrode using a metal laser cutter. The length of the uncut electrode and width of the helical cuts have to be small enough to fit through the curved needle tip and flexible enough to allow the electrode to bend. The smaller the distance between the helical cuts the weaker the electrode is in terms of tensile strength but the lower the force required to pass through the needle. The wall thickness of the electrode is approximately 08 mm.
During lead insertion, a stylet 410 may be used to stiffen the lead. A stylet retention endcap made of MP35N may be used to prevent the stylet wire from perforating the end of the lead and causing patient harm. Alternatively, the stylet 410 may be manufactured as part of the lead and be used to increase the tensile strength of the lead and be glues in place. The smaller the cross-sectional area of the lead the lower its tensile strength will be. A nitinol stylet may be used to increase tensile strength while improving the leads ability to return back to its original shape. Testing showed that tensile strength could be increased to >9N with less than 20% elongation over 1 minute versus tensile strength was between 4.5 to 5N under the same test conditions without the use of a 6 thou nitinol stiffening member.
There are many different shapes that can be cut into the electrode that will provide adequate flexibility and ultrasound visibility.
In addition to the details and descriptions provided above, the following publications should be considered as part of the present disclosure.
Merrill D R, Bikson M, Jefferys J G. Electrical stimulation of excitable tissue: design of efficacious and safe protocols. J Neurosci Methods. 2005 Feb. 15;141(2):171-98. Review. PubMed PMID: 15661300; the entire contents of which are incorporated herein by reference.
McCreery D B, Agnew W F, Yuen T G H, Bullara L. “Charge density and charge per phase as cofactors in neural injury induced by electrical stimulation,” IEEE Trans. Biomed. Eng., vol. 37(10):996-1001; the entire contents of which are incorporated herein by reference.
McCreery D B, Agnew W F, Yuen T G H, Bullara L. “Comparison of neural damage induced by electrical stimulation with faradic and capacitor electrodes,” Ann. Biomed. Eng., vol. 16(5):463-81; the entire contents of which are incorporated herein by reference.
Shannon R V “A model of safe levels for electrical stimulation.” Biomedical Engineering, IEEE Transactions 39: 424-426; the entire contents of which are incorporated herein by reference.
The many features and advantages of the invention are apparent from the above description. Numerous modifications and variations will readily occur to those skilled in the art. Since such modifications are possible, the invention is not to be limited to the exact construction and operation illustrated and described. Rather, the present invention should be limited only by the following claims.
This application is a Utility filing claiming priority to U.S. Provisional Application No. 62/529,048, filed on Jul. 6, 2017 and entitled: “Lead Design”, the entire contents of which is incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
62529048 | Jul 2017 | US |